Guinea

Guinea: the results from the study of favipiravir for treatment against ebola prove to be nuanced

01/16/2018

Dakar/ Paris, March 3 2016. Yesterday, the journal PLOS Medicine published “encouraging but nuanced” conclusions on the trials for the Favipiravir treatment against the Ebola virus. According to

Happy to be alive

04/21/2017

Tonhon Bolamou was just 10-years-old when she contracted the Ebola virus in March 2016. After spending 13 days in the Ebola Treatment Center in N’Zerekore, in southeastern Guinea,

Three years on, Ebola survivors in Guinea still need support

04/13/2017

N’ZEREKORE/DAKAR – Three years after the Ebola outbreak was first declared by Guinea’s Ministry of Health, many survivors continue to suffer from physical and mental health problems. The

Clinical trial on Ebola in Guinea

03/27/2017

ALIMA conducted a clinical trial on Ebola in Guinea. Watch the video.

VOIR +

Subscribe to our monthly newsletter

By subscribing to the ALIMA newsletter, you agree to receive information from us. You can unsubscribe at any time using the unsubscribe links. To understand the use of your data collected by this form, please consult our privacy policy.

Contact Legal notice Press Cookies

For the United States: 100% of your donation will be tax-deductible. ALIMA USA, Inc., is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 26-0397519.
For France: Association Law 1901 – Registration and SIREN number : 831 620 398

Under the French tax system, you will benefit from an income tax reduction of 75% of the amount of your donations up to a maximum of 1 000 euros. Beyond that amount, donations are 66% tax deductible up to an equivalent of 20% of your taxable income.